At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 75 enrolled
Drug / intervention
adapalene cream 0.1% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Split-Face Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
In Brief
A Phase 1 clinical trial evaluating adapalene cream 0.1% and adapalene lotion 0.1% for Skin Manifestations. Completed, enrolled 75 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the tolerability of Differin® (adapalene) Cream, 0.1% to Differin® Lotion, 0.1% in subjects with healthy skin treated once a day for three (3) weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Manifestations
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
First PostedJan 2010
Primary CompletionFeb 2010
TodayJul 2026
First PostedJan 12, 2010
Enrollment StartJan 1, 2010
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.5 years ago
Interventions
adapalene cream 0.1%drug
adapalene cream 0.1% - apply once daily on one side of the face for 3 weeks
adapalene lotion 0.1%drug
adapalene lotion 0.1% - apply once daily on the opposite side of the face for 3 weeks